ROBIN HOWARD W (President & CEO) sold 2.2% of their position (1.50K shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $45.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/4/2025ACC: 0000950170-25-113129
DirectorOfficer· President & CEO
Since Aug 2018
-1.50K
Net shares
Net seller
$45.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.50K
Price / share
$30.16
Trade value
$45.24K
% of position
2.2%
9/2/2025
69.34K→67.84K
Total
Net shares
−1.50K
Net value
-$45.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | S · Sale | −1.50K | $30.16 | $45.24K | 2.2% | 69.34K | 67.84K |
| Total | −1.50K | -$45.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned28.00
Total
28.00 indirect28.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.00 | Indirect |
| Total | 28.00 | 28.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported